Bedrocan Cannabis (FRA:8BC) EBIT : €-1.17 Mil (TTM As of Apr. 2015)

View and export this data going back to . Start your Free Trial

What is Bedrocan Cannabis EBIT?

Bedrocan Cannabis's earnings before interest and taxes (EBIT) for the three months ended in Apr. 2015 was €-0.75 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Apr. 2015 was €-1.17 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bedrocan Cannabis's annualized ROC % for the quarter that ended in Apr. 2015 was -24.35%. Bedrocan Cannabis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2015 was -24.70%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bedrocan Cannabis's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Apr. 2015 was -3.29%.

Bedrocan Cannabis EBIT Historical Data

The historical data trend for Bedrocan Cannabis's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bedrocan Cannabis EBIT Chart

Bedrocan Cannabis Annual Data

Trend

Jan13

Jan14

Jan15

EBIT

-0.08

Bedrocan Cannabis Quarterly Data
	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15
EBIT	Get a 7-Day Free Trial					-0.01	-0.12	-0.30	-	-0.75

Competitive Comparison of Bedrocan Cannabis's EBIT

For the Biotechnology subindustry, Bedrocan Cannabis's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bedrocan Cannabis's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bedrocan Cannabis's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bedrocan Cannabis's EV-to-EBIT falls into.

Bedrocan Cannabis EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Apr. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.17 Mil.

Bedrocan Cannabis (FRA:8BC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bedrocan Cannabis's annualized ROC % for the quarter that ended in Apr. 2015 is calculated as:

	ROC % (Q: Apr. 2015 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jan. 2015 )	+	Invested Capital (Q: Apr. 2015 ))	/ count )
=	-3 * ( 1 - 0% )	/	( (11.315	+	13.324)	/ 2 )
=	-3	/	12.3195
=	-24.35 %

where

	Invested Capital		(Q: Jan. 2015 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	16.351	-	4.678	-	( 2.926	-	max(0, 4.801	-	5.159	+	2.926	))
=	11.315

	Invested Capital		(Q: Apr. 2015 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	16.218	-	2.654	-	( 1.772	-	max(0, 2.883	-	3.123	+	1.772	))
=	13.324

Note: The Operating Income data used here is four times the quarterly (Apr. 2015) data.

2. Joel Greenblatt's definition of Return on Capital:

Bedrocan Cannabis's annualized ROC (Joel Greenblatt) % for the quarter that ended in Apr. 2015 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Apr. 2015 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jan. 2015		Q: Apr. 2015
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-3	/	( ( (11.192 + max(-4.554, 0))	+	(13.095 + max(-1.811, 0)) )	/	2 )
=	-3	/	( ( 11.192	+	13.095 )	/	2 )
=	-3	/	12.1435
=	-24.70 %

where Working Capital is:

	Working Capital		(Q: Jan. 2015 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.055	+	0.143	+	0.049)	-	(4.678	+	0	+	0.123)
=	-4.554

	Working Capital		(Q: Apr. 2015 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.103	+	0.262	+	0.608)	-	(2.654	+	0	+	0.13)
=	-1.811

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Apr. 2015) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bedrocan Cannabis's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Apr. 2015 )
	=	-1.169	/	35.515
	=	-3.29 %

Bedrocan Cannabis EBIT Related Terms

Thank you for viewing the detailed overview of Bedrocan Cannabis's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bedrocan Cannabis (FRA:8BC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bedrocan Cannabis Corp (FRA:8BC) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.bedrocan.ca

POCML 2 Inc is a capital pool company. The Company will not carry on any business other than the identification and evaluation of assets or businesses with a view to completing a proposed Qualifying Transaction.

Bedrocan Cannabis (FRA:8BC) Headlines

No Headlines